Detalles de la búsqueda
1.
Ectopic calcification in ß-thalassemia patients is associated with increased oxidative stress and lower MGP carboxylation.
Biochim Biophys Acta
; 1832(12): 2077-84, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23899606
2.
Hepatocellular carcinoma in thalassaemia: an update of the Italian Registry.
Br J Haematol
; 167(1): 121-6, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24992281
3.
Serial echocardiographic left ventricular ejection fraction measurements: a tool for detecting thalassemia major patients at risk of cardiac death.
Blood Cells Mol Dis
; 50(4): 241-6, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23337255
4.
Long-term treatment with deferiprone enhances left ventricular ejection function when compared to deferoxamine in patients with thalassemia major.
Blood Cells Mol Dis
; 51(2): 85-8, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23628348
5.
Cardiac and hepatic iron and ejection fraction in thalassemia major: multicentre prospective comparison of combined deferiprone and deferoxamine therapy against deferiprone or deferoxamine monotherapy.
J Cardiovasc Magn Reson
; 15: 1, 2013 Jan 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-23324167
6.
Management of chronic viral hepatitis in patients with thalassemia: recommendations from an international panel.
Blood
; 116(16): 2875-83, 2010 Oct 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-20551378
7.
Long-term use of deferiprone significantly enhances left-ventricular ejection function in thalassemia major patients.
Am J Hematol
; 87(7): 732-3, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22622672
8.
Iron chelation therapy in thalassemia major: a systematic review with meta-analyses of 1520 patients included on randomized clinical trials.
Blood Cells Mol Dis
; 47(3): 166-75, 2011 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21843958
9.
Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging.
Haematologica
; 96(1): 41-7, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20884710
10.
Malignancies in ß-thalassemia patients: first description of two cases of thyroid cancer and review of the literature.
Hemoglobin
; 35(4): 439-46, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21797713
11.
Sequential alternating deferiprone and deferoxamine treatment compared to deferiprone monotherapy: main findings and clinical follow-up of a large multicenter randomized clinical trial in -thalassemia major patients.
Hemoglobin
; 35(3): 206-16, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21599433
12.
Increased survival and reversion of iron-induced cardiac disease in patients with thalassemia major receiving intensive combined chelation therapy as compared to desferoxamine alone.
Blood Cells Mol Dis
; 45(2): 136-9, 2010 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20678715
13.
Long-term sequential deferiprone-deferoxamine versus deferiprone alone for thalassaemia major patients: a randomized clinical trial.
Br J Haematol
; 145(2): 245-54, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19236376
14.
Improving survival with deferiprone treatment in patients with thalassemia major: a prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies.
Blood Cells Mol Dis
; 42(3): 247-51, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19233692
15.
Improved T2* assessment in liver iron overload by magnetic resonance imaging.
Magn Reson Imaging
; 27(2): 188-97, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18667287
16.
Pain syndromes in sickle cell disease: an update.
Pain Med
; 10(3): 470-80, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19416438
17.
[Laparoscopic splenectomy in haematological diseases: short- and medium-term results in thirty initial cases]. / La splenectomia laparoscopica nelle patologie ematologiche: risultati a breve e medio terrnine in trenta casi iniziali.
Chir Ital
; 61(4): 427-33, 2009.
Artículo
en Italiano
| MEDLINE | ID: mdl-19845264
18.
Giant symptomatic myelolipoma of the right adrenal gland: a case report.
Chir Ital
; 61(2): 231-6, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19536999
19.
Anemia in beta-thalassemia patients targets hepatic hepcidin transcript levels independently of iron metabolism genes controlling hepcidin expression.
Haematologica
; 93(1): 111-5, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18166793
20.
Treatment of iron overload in thalassemia.
Pediatr Endocrinol Rev
; 6 Suppl 1: 208-13, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19337180